J R Hampton - Concepedia

Author

J R Hampton

Also Known As

HAMPTON, J.R., J Hampton, J Hampton3, J R Hampton, J. Hampton, J. R Hampton, J. R. HAMPTON, J. R. Hampton, J.R Hampton, J.R. HAMPTON

166

Publications

8.1K

Citations

H-Index

142

Concepts

All Affiliations

University of Nottingham Queen's Medical Centre Nottingham General Hospital British Heart Foundation University of Oxford

About

J R Hampton is an author at University of Nottingham specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	59	4.1K
2	Health Sciences	12	14	680
3	Engineering	2	2	68
4	Education	1	1	45
5	Natural Sciences	1	1	16

J R Hampton

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Robert G. Wilcox, Carl Olsson, Allan M. Skene, The Lancet ThrombosisCardiovascular DiseaseCardiologyAcute Myocardial InfarctionMedicine	1988	1.2K
Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. J R Hampton, Margaret J. Harrison, J.R.A. Mitchell, BMJ	1975	1K
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population Nigel Brown, M Melville, Denis Pereira Gray, Heart	1999	249
Do women with acute myocardial infarction receive the same treatment as men? Katy Clarke, Denis Pereira Gray, N A Keating, BMJ	1994	212
Evidence of inadequate investigation and treatment of patients with heart failure. Katy Clarke, Denis Pereira Gray, J R Hampton Heart	1994	196
A RANDOMISED TRIAL OF HOME-VERSUS-HOSPITAL MANAGEMENT FOR PATIENTS WITH SUSPECTED MYOCARDIAL INFARCTION James Hill, J R Hampton, J.R.A. Mitchell The Lancet Health PolicyCardiovascular DiseaseMyocardial InfarctionPatient SafetyOutcomes Research	1978	185
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Gabriel I. Barbash, Harvey D. White, Michaela Modan, Circulation	1993	184
Trial of early nifedipine in acute myocardial infarction: the Trent study. Robert A. Wilcox, J R Hampton, D C Banks, BMJ Consecutive PatientsThrombosisHeart FailureTrent StudyDouble Blind Study	1986	182
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. P.R. Emmons, J R Hampton, M J Harrison, BMJ ImmunologyProstaglandin E1Platelet AggregationInflammationThrombosis	1967	177
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Harvey D. White, Gabriel I. Barbash, Michaela Modan, Circulation	1993	166

Page 1